CGC Stock Analysis: Buy, Sell, or Hold?
CGC - Canopy Growth Corporation Common Shares
$1.04
-0.03 (-2.80%)
▼
5d:
-6.31%
30d:
-9.57%
90d:
-3.7%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 29, 2026
10d
Smart Money Accumulation
CGC is down 6.3% this week, but smart money is accumulating calls. Top strike: $1.5 2026-07-17 with 23,482 OI. Call ratio: 80% View Scanner →
Strength: 6.2/10
Get Alerted When CGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called CGC this week
57% bullish • 3 bearish
57% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CGC is currently trading at $1.04, which is considered oversold relative to its 30-day fair value range of $1.05 to $1.19. From a valuation perspective, the stock is trading at a discount (Forward PE: -4.1) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CGC is in a downtrend. The price is currently testing key support at $1.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.79 (+71.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGC is in a downtrend. The price is currently testing key support at $1.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.79 (+71.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.05 -
$1.19
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding CGC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.9% below Wall St target ($1.79)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.05 -
$1.19
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.02
Resistance Level
$1.16
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.06
Wall Street Target
$1.79
(+71.9%)
Revenue Growth (YoY)
-0.3%
Profit Margin
-117.3%
PE vs Historical
-4.1 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 7:31 AM ET
Data refreshes hourly during market hours. Next update: 8:31 AM
Data refreshes hourly during market hours. Next update: 8:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Bayern
SELL
2658 shares
2026-03-31
M Shan Atkins
SELL
2074 shares
2026-03-31
Theresa Yanofsky
SELL
10373 shares
2026-03-31
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$131 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
Advanced CGC Option Strategies
Professional options setups generated by AI based on today's CGC price and gamma walls.
